1 / 2

Patients (%)

Figure 1. FREEDOM: PGIC Scores at End Point. 80. Worse*. P < 0.0001. No change. P < 0.0001. P= 0.0002. Improved**. 60. 40. Patients (%). 20. 0. Placebo (n=374). Pregabalin 450 mg/day (n=373). Pregabalin 600 mg/day (n=378). Pregabalin 300 mg/day (n=368).

ziazan
Download Presentation

Patients (%)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 1. FREEDOM: PGIC Scores at End Point 80 Worse* P<0.0001 No change P<0.0001 P=0.0002 Improved** 60 40 Patients (%) 20 0 Placebo (n=374) Pregabalin 450 mg/day (n=373) Pregabalin 600 mg/day (n=378) Pregabalin 300 mg/day (n=368) *Includes minimally worse, much worse, and very much worse categories **Includes very much improved, much improved and minimally improved categories Adapted from: Duan et al. ACR 2007.

  2. Figure 2. Duration of Treatment at One Year 180 n=172 160 140 n=114 120 100 80 Number of pregabalin patients n=56 60 n=46 40 n=18 n=17 20 n=6 0 ≤ 1 2-14 15-28 29-90 91-180 181-364 ≥365 Duration (days) Adapted from: Florian et al. ACR 2007.

More Related